Marshall Wace North America’s Cross Country Healthcare CCRN Stock Holding History

Marshall Wace North America’s Portfolio CCRN Stock Details CCRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-25,147	Closed	-$223K	–	1531
2020 Q4	$223K	Buy	+25,147	New	+$205K	﹤0.01%	1213
2019 Q4	–	Sell	-2,189	Closed	-$23K	–	1315
2019 Q3	$23K	Buy	+2,189	New	+$21.5K	﹤0.01%	1223
2018 Q3	–	Sell	-71,411	Closed	-$803K	–	961
2018 Q2	$803K	Buy	+71,411	New	+$852K	﹤0.01%	991
2017 Q3	–	Sell	-46,393	Closed	-$603K	–	1272
2017 Q2	$603K	Buy	46,393 +15,987	+53%	+$206K	﹤0.01%	1058
2017 Q1	$426K	Buy	+30,406	New	+$448K	﹤0.01%	833

Other funds holding CCRN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACB

Aristotle Capital Boston Boston, Massachusetts $1.61B AUM 19.82% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

SFM

Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Marshall Wace North America's CCRN Position: Q1 2021 in Review

Marshall Wace North America sold out of Cross Country Healthcare (CCRN) in Q1 2021, closing a stake of 25,147 shares — an estimated $223K sold.

Marshall Wace North America first reported a position in CCRN in Q1 2017 and held it in 5 quarters. The position peaked at $803K in Q2 2018. 129 funds tracked by Wall St. Rank hold CCRN as of Q1 2021.

Marshall Wace North America reported no remaining Cross Country Healthcare position as of Q1 2021 after selling out during the quarter.
Marshall Wace North America sold 25,147 Cross Country Healthcare shares in Q1 2021, an estimated $223K.
Marshall Wace North America first reported a position in Cross Country Healthcare in Q1 2017 and held it in 5 quarters.
Marshall Wace North America's Cross Country Healthcare position peaked at $803K in Q2 2018.
129 funds tracked by Wall St. Rank held Cross Country Healthcare as of Q1 2021.

Based on Marshall Wace North America's 13F filing for Q1 2021, filed 17 May 2021.